title: C reactive protein is associated with malignant ventricular arrhythmias in patients with ischaemia with implantable cardioverter-defibrillator.
authors.forename: L M
authors.initials: LM
authors.lastname: Biasucci
authors.forename: G
authors.initials: G
authors.lastname: Giubilato
authors.forename: G
authors.initials: G
authors.lastname: Biondi-Zoccai
authors.forename: T
authors.initials: T
authors.lastname: Sanna
authors.forename: G
authors.initials: G
authors.lastname: Liuzzo
authors.forename: M
authors.initials: M
authors.lastname: Piro
authors.forename: G
authors.initials: G
authors.lastname: De Martino
authors.forename: C
authors.initials: C
authors.lastname: Ierardi
authors.forename: A
authors.initials: A
authors.lastname: dello Russo
authors.forename: G
authors.initials: G
authors.lastname: Pelargonio
authors.forename: F
authors.initials: F
authors.lastname: Bellocci
authors.forename: F
authors.initials: F
authors.lastname: Crea
mesh_terms: D000368:Aged; D001145:Arrhythmias, Cardiac / Q000175:diagnosis* / Q000628:therapy; D015415:Biomarkers / Q000378:metabolism; D002097:C-Reactive Protein / Q000378:metabolism*; D016757:Death, Sudden, Cardiac; D017147:Defibrillators, Implantable; D005260:Female; D006801:Humans; D008297:Male; D017202:Myocardial Ischemia / Q000150:complications*
chemical_list: D015415:Biomarkers; D002097:C-Reactive Protein